These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12362272)

  • 1. The p53 network in lung carcinogenesis.
    Robles AI; Linke SP; Harris CC
    Oncogene; 2002 Oct; 21(45):6898-907. PubMed ID: 12362272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 and lung cancer.
    Brambilla E; Brambilla C
    Pathol Biol (Paris); 1997 Dec; 45(10):852-63. PubMed ID: 9769949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
    Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
    Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke.
    De Flora S; Balansky RM; D'Agostini F; Izzotti A; Camoirano A; Bennicelli C; Zhang Z; Wang Y; Lubet RA; You M
    Cancer Res; 2003 Feb; 63(4):793-800. PubMed ID: 12591728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer.
    Bennett WP; Hussain SP; Vahakangas KH; Khan MA; Shields PG; Harris CC
    J Pathol; 1999 Jan; 187(1):8-18. PubMed ID: 10341702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
    Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
    Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
    Osada H; Takahashi T
    Oncogene; 2002 Oct; 21(48):7421-34. PubMed ID: 12379883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis.
    Soussi T; Dehouche K; Béroud C
    Hum Mutat; 2000; 15(1):105-13. PubMed ID: 10612830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biology of head and neck tumorigenesis: the role of p53 expression and genetic instability.
    Charuruks N; Voravud N
    J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S3-10. PubMed ID: 9071061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression in the lung of p53 mutant mice exposed to cigarette smoke.
    Izzotti A; Cartiglia C; Longobardi M; Bagnasco M; Merello A; You M; Lubet RA; De Flora S
    Cancer Res; 2004 Dec; 64(23):8566-72. PubMed ID: 15574763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 Arg72Pro polymorphism predicts survival outcome in lung cancer patients in Indian population.
    Sreeja L; Syamala V; Raveendran PB; Santhi S; Madhavan J; Ankathil R
    Cancer Invest; 2008 Feb; 26(1):41-6. PubMed ID: 18181044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
    Hu Y; McDermott MP; Ahrendt SA
    Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cell cycle, tumor suppressor genes and lung cancers].
    Bréchot JM
    Rev Mal Respir; 1998 Sep; 15(4):461-6. PubMed ID: 9805756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.
    Olivier M; Hussain SP; Caron de Fromentel C; Hainaut P; Harris CC
    IARC Sci Publ; 2004; (157):247-70. PubMed ID: 15055300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [TP53 mutations and molecular epidemiology].
    Otsuka K; Ishioka C
    Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
    Chien WP; Wong RH; Wu TC; Cheng YW; Chen CY; Lee H
    Ann Surg Oncol; 2009 Jul; 16(7):1918-24. PubMed ID: 19434453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke.
    Yao R; Wang Y; D'Agostini F; Izzotti A; Lubet RA; You M; De Flora S
    Exp Lung Res; 2005 Mar; 31(2):271-81. PubMed ID: 15824025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.